Non-hodgkin Lymphoma
📧 Sign up to get email alerts when something new happens for Non-hodgkin Lymphoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-01-28Clinical Trial Update: Study of AXT-1003 in Subjects With Advanced Malignant Tumors. [Phase 1]
Phase 1 clinical trial update for AXT-1003 in subjects with advanced malignant tumors. The study is currently recruiting for Non-Hodgkin lym…
-
CLINICAL_TRIALS research · 2026-01-26Clinical Trial Update: Study to Evaluate Adverse Events, Change in Disease Activity, and How Intravenously Infused ABBV-291 Moves Through the Body in Adult Participants With Non-Hodgkin's Lymphoma [Phase 1]
Phase 1 study evaluating safety, adverse events, changes in disease activity, and pharmacokinetics of intravenously infused ABBV-291 in adul…
-
CLINICAL_TRIALS research · 2026-01-22Clinical Trial Update: Transgene Assay Testing Service of Tumor Samples From Patients Who Received a Bristol-Myers Squibb Manufactured Gene Modified Cell Therapy and Have a Qualifying Second Primary Malignancy
Clinical trial update describing a Bristol-Myers Squibb-sponsored study to perform transgene assay testing on tumor samples from patients wh…
-
CLINICAL_TRIALS research · 2026-01-22Clinical Trial Update: Cord Blood Transplant, Cyclophosphamide, Fludarabine, and Total-Body Irradiation in Treating Patients With High-Risk Hematologic Diseases [Phase 2]
Phase 2 clinical trial evaluating a cord blood transplant using cyclophosphamide, fludarabine, and total-body irradiation in high-risk hemat…
-
CLINICAL_TRIALS research · 2026-01-15Clinical Trial Update: PET Imaging of Cancer Patients Using 124I-PUH71: A Pilot Study [EARLY_Phase 1]
Early-phase 1 pilot study investigating PET imaging of cancer patients with the radiopharmaceutical 124I-PUH71, with the trial status curren…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-01-15Clinical Trial Update: AYAHIV Role-based Responsibilities for Oncology-focused Workforce (ARROW) [NA]
The ARROW clinical trial, sponsored by Implenomics, is currently recruiting to study AYAHIV role-based responsibilities for an oncology-focu…
-
CLINICAL_TRIALS research · 2026-01-14Clinical Trial Update: Anti-CD19 Chimeric Antigen Receptor T Cells for Treatment of Relapsed or Refractory Non-Hodgkin Lymphoma [Phase 1]
This is a Phase 1 trial evaluating anti-CD19 CAR-T cell therapy for relapsed or refractory non-Hodgkin lymphoma. The study is currently recr…
-
CLINICAL_TRIALS research · 2026-01-12Clinical Trial Update: A Phase 1 Study of UB-VV111 With and Without Rapamycin in Relapsed/Refractory CD19+ B-cell Malignancies [Phase 1]
A Phase 1 clinical trial evaluating UB-VV111 with and without rapamycin for relapsed/refractory CD19+ B-cell malignancies is currently recru…
-
CLINICAL_TRIALS research · 2026-01-07Clinical Trial Update: Palifermin With Leuprolide Acetate for the Promotion of Immune Recovery Following Total Body Irradiation Based T-Cell Depleted Allogeneic Hematopoietic Stem Cell Transplantation [Phase 2]
Phase 2 clinical trial evaluating palifermin in combination with leuprolide acetate to promote immune recovery after total body irradiation-…
-
CLINICAL_TRIALS research · 2026-01-07Clinical Trial Update: Ascertainment of Peripheral Blood or Saliva Samples for Genetic Epidemiology Studies of Familial Cancers
The document describes an ongoing clinical trial that collects peripheral blood or saliva samples for genetic epidemiology studies of famili…
-
CLINICAL_TRIALS research · 2026-01-06Clinical Trial Update: Low-Dose Selinexor and Choline Salicylate for Non-Hodgkin or Hodgkin Lymphoma, Histiocytic/Dendritic Cell Neoplasm, or Relapsed or Refractory Multiple Myeloma [Phase 1]
A Phase 1 trial at Mayo Clinic evaluating low-dose selinexor in combination with choline salicylate for relapsed or refractory Hodgkin lymph…
-
CLINICAL_TRIALS research · 2026-01-06Clinical Trial Update: Study of CD30 CAR for Relapsed/Refractory CD30+ HL and CD30+ NHL [Phase 1, Phase 2]
Update on a CD30-targeted CAR-T cell therapy being studied for relapsed/refractory Hodgkin lymphoma and CD30+ Non-Hodgkin lymphoma in Phase …
-
CLINICAL_TRIALS research · 2026-01-06Clinical Trial Update: Clinical Study of Novel TLR2-Containing CAR-T Cells Targeting CD19 and CD22 for Relapsed/Refractory B-ALL and NHL [EARLY_Phase 1]
An early-phase Phase 1 study of a novel TLR2-containing CAR-T cell therapy targeting CD19 and CD22 for relapsed/refractory B-cell acute lymp…
-
CLINICAL_TRIALS research · 2026-01-05Clinical Trial Update: Activated T-Cells Expressing 2nd or 3rd Generation CD19-Specific CAR, Advanced B-Cell NHL, ALL, and CLL (SAGAN) [Phase 1]
Phase 1 trial evaluating activated T cells expressing second- or third-generation CD19-directed CAR-T cells in advanced B-cell malignancies.…
-
CLINICAL_TRIALS research · 2026-01-05Clinical Trial Update: The Feasibility and Clinical Efficacy of Atezolizumab Consolidation Treatment in High Risk (IPI > 2) DLBCL [Phase 2]
A phase 2 clinical trial is evaluating the feasibility and clinical efficacy of atezolizumab as consolidation therapy in high-risk diffuse l…
-
CLINICAL_TRIALS research · 2026-01-02Clinical Trial Update: PAX5-NEGATIVE HODGKIN-LIKE LYMPHOMAS: A DIAGNOSTIC CHALLANGE
A clinical trial update focusing on diagnosing PAX5-negative Hodgkin-like lymphomas, highlighting the diagnostic challenges in Hodgkin and n…
-
CLINICAL_TRIALS research · 2025-12-31Clinical Trial Update: Clinical Study of LV009 Injection for the Treatment of Relapsed/Refractory CD19-Positive Hematologic and Lymphoid Malignancies [EARLY_Phase 1]
This clinical trial update describes an early-phase (Phase 1) study of LV009 injection for relapsed/refractory CD19-positive hematologic and…
-
CLINICAL_TRIALS research · 2025-12-29Clinical Trial Update: Radiation Dose Study for Relapsed/Refractory Hodgkin/Non-Hodgkin Lymphoma [NA]
An ongoing radiation dose study for relapsed/refractory Hodgkin lymphoma and non-Hodgkin lymphoma is currently active but not recruiting.
-
CLINICAL_TRIALS research · 2025-12-29Clinical Trial Update: PET Imaging Study of 64Cu-GRIP B for Patients Receiving CD19-directed CAR-T Therapy [Phase 1]
A Phase 1 PET imaging study using the radiotracer 64Cu-GRIP B in patients receiving CD19-directed CAR-T therapy for non-Hodgkin lymphoma is …
-
CLINICAL_TRIALS research · 2025-12-24Clinical Trial Update: A Dose Escalation and Dose Expansion Study of Intratumoral ONM-501 Alone and in Combination With Cemiplimab in Patients With Advanced Solid Tumors and Lymphomas. [Phase 1]
This is a Phase 1 dose-escalation and expansion study evaluating intratumoral ONM-501 alone and in combination with cemiplimab in patients w…
-
CLINICAL_TRIALS research · 2025-12-24Clinical Trial Update: Clinical and Pathologic Studies in Non-Hodgkin's Lymphoma and Hodgkin's Disease
A Stanford University–sponsored clinical trial is recruiting to study clinical and pathologic aspects of Non-Hodgkin lymphoma and Hodgkin ly…
-
CLINICAL_TRIALS research · 2025-12-19Clinical Trial Update: A Study to Assess PK, Safety and Efficacy of HSK47977 Tablets in Subjects With Relapsed or Refractory Non-Hodgkin's Lymphoma [Phase 1]
This Phase 1 trial is evaluating pharmacokinetics, safety, and preliminary efficacy of HSK47977 tablets in adults with relapsed or refractor…
-
CLINICAL_TRIALS research · 2025-12-18Clinical Trial Update: To Assess the Safety and Tolerability of Tafasitamab Alone or in Combination With Other Drugs in Japanese Participants With Non-Hodgkins Lymphoma (NHL) [Phase 1, Phase 2]
A Phase 1/2 clinical trial update assessing the safety and tolerability of tafasitamab alone or in combination with other drugs in Japanese …
-
CLINICAL_TRIALS research · 2025-12-18Clinical Trial Update: Study to Evaluate CCS1477 (Inobrodib) in Haematological Malignancies [Phase 1, Phase 2]
A Phase 1/2 study is evaluating CCS1477 (Inobrodib) in multiple hematologic malignancies and is currently recruiting.
-
CLINICAL_TRIALS research · 2025-12-16Clinical Trial Update: Clinical Study of LV009 Injection for the Treatment of Hematologic and Lymphoid Malignancies [Phase 1]
Phase 1 clinical trial update for LV009 injection in hematologic and lymphoid cancers, including Non-Hodgkin Lymphoma and Acute Lymphoblasti…